Sentinel Asset Management’s Gilead Sciences GILD Stock Holding History

Sentinel Asset Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-314,300	Closed	-$24.9M	–	190
2016 Q3	$24.9M	Hold	314,300	–	–	0.59%	62
2016 Q2	$26.2M	Sell	314,300 -11,600	-4%	-$1.03M	0.62%	61
2016 Q1	$29.9M	Buy	325,900 +500	+0.2%	+$45.1K	0.67%	46
2015 Q4	$32.9M	Buy	325,400 +3,100	+1%	+$323K	0.83%	42
2015 Q3	$31.6M	Buy	322,300 +1,000	+0.3%	+$111K	0.81%	39
2015 Q2	$37.6M	Buy	321,300 +1,800	+0.6%	+$197K	0.86%	32
2015 Q1	$31.4M	Sell	319,500 -21,400	-6%	-$2.17M	0.68%	54
2014 Q4	$32.1M	Buy	340,900 +17,100	+5%	+$1.77M	0.67%	57
2014 Q3	$34.5M	Hold	323,800	–	–	0.71%	49
2014 Q2	$26.8M	Hold	323,800	–	–	0.53%	71
2014 Q1	$22.9M	Sell	323,800 -132,200	-29%	-$10.4M	0.45%	91
2013 Q4	$34.3M	Sell	456,000 -50,980	-10%	-$3.55M	0.66%	42
2013 Q3	$31.9M	Sell	506,980 -980	-0.2%	-$58.6K	0.67%	39
2013 Q2	$26M	Buy	+507,960	New	+$26.5M	0.56%	56

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sentinel Asset Management's GILD Position: Q4 2016 in Review

Sentinel Asset Management sold out of Gilead Sciences (GILD) in Q4 2016, closing a stake of 314,300 shares — an estimated $24.9M sold.

Sentinel Asset Management first reported a position in GILD in Q2 2013 and held it in 14 quarters. The position peaked at $37.6M in Q2 2015. 1,572 funds tracked by Wall St. Rank hold GILD as of Q4 2016.

Sentinel Asset Management reported no remaining Gilead Sciences position as of Q4 2016 after selling out during the quarter.
Sentinel Asset Management sold 314,300 Gilead Sciences shares in Q4 2016, an estimated $24.9M.
Sentinel Asset Management first reported a position in Gilead Sciences in Q2 2013 and held it in 14 quarters.
Sentinel Asset Management's Gilead Sciences position peaked at $37.6M in Q2 2015.
1,572 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2016.

Based on Sentinel Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.